Page last updated: 2024-08-23

epirubicin and Cardiac Remodeling, Ventricular

epirubicin has been researched along with Cardiac Remodeling, Ventricular in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bergler-Klein, J; Gugerell, A; Gyöngyösi, M; Jakab, A; Lukovic, D; Maurer, G; Pavo, N; Pils, D; Pircher, A; Riesenhuber, M; Spannbauer, A; Traxler, D; Winkler, J; Zlabinger, K	1
Han, Q; Hu, R; Irwin, DM; Li, H; Man, Z; Mao, Y; Niu, G; Tan, H; Wang, X; Zhang, J; Zhang, Q; Zhang, X	1

Other Studies

2 other study(ies) available for epirubicin and Cardiac Remodeling, Ventricular

Article	Year
Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance. Cardiovascular research, 2020, 04-01, Volume: 116, Issue:5 Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotoxicity; Cells, Cultured; Collagen; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Compounding; Epirubicin; Female; Fibrosis; Humans; Interferon Regulatory Factors; Myocytes, Cardiac; Polyethylene Glycols; Sus scrofa; Transcriptome; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling	2020
Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy. Journal of ethnopharmacology, 2016, Nov-04, Volume: 192 Topics: Animals; Autophagy; Cardiotonic Agents; Cardiotoxicity; Collagen; Disease Models, Animal; Drugs, Chinese Herbal; Epirubicin; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Heart Diseases; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 9; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Stroke Volume; Time Factors; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling	2016

Article

Year

Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.

Cardiovascular research, 2020, 04-01, Volume: 116, Issue:5

Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotoxicity; Cells, Cultured; Collagen; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Compounding; Epirubicin; Female; Fibrosis; Humans; Interferon Regulatory Factors; Myocytes, Cardiac; Polyethylene Glycols; Sus scrofa; Transcriptome; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling

2020

Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.

Journal of ethnopharmacology, 2016, Nov-04, Volume: 192

Topics: Animals; Autophagy; Cardiotonic Agents; Cardiotoxicity; Collagen; Disease Models, Animal; Drugs, Chinese Herbal; Epirubicin; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Heart Diseases; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 9; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Stroke Volume; Time Factors; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2016